StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Hepion Pharmaceuticals's price to book ratio was 2.3× on Oct 19, 2026, against 0.2× a year earlier. Over the last 5 years it ranged from 0.1× to 11.4×, with a median of 0.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20262.3×+2.1
2025Dec 31, 20250.2×−7.8
2024Dec 31, 20248.0×+7.3
2023Dec 29, 20230.8×+0.4
2022Dec 30, 20220.4×−0.5
2021Dec 31, 20210.8×−0.7
2020Dec 31, 20201.5×+0.4
2019Dec 31, 20191.2×+0.9
2018Dec 31, 20180.3×−2.7
2017Dec 29, 20173.0×−46.8
2016Oct 31, 201649.8×+39.3
2015Oct 30, 201510.5×−81.6
2014Dec 31, 201492.1×–

More Hepion Pharmaceuticals figures

See a number that looks wrong?